Market News & Trends
Pace Life Sciences Announces Compliant US FDA Inspection of Operations in Research Triangle Park, NC
RALEIGH, NC Pace® Life Sciences, a U.S.-based, FDA-registered GMP analytical testing laboratory and full-service contract research, development, and manufacturing organization (CDMO), and a Division of Pace®,…
Decoy Therapeutics Announces Breakthrough In Vitro Activity Against Ebola Zaire, Expanding D-MAV™ Platform into High Consequence Global Health Threats
CAMBRIDGE, Mass., -- Decoy Therapeutics Inc. (Nasdaq: DCOY), a biotechnology company developing Designable Multi-Antivirals (D-MAVs™), today announced that one of its D-MAV candidates demonstrates in…
ITM Introduces Lumara Bio as Its New Oncology Therapeutics Division
Garching / Munich, Germany and Princeton, New Jersey, - ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today introduced Lumara Bio as a…
Nemera and SCHOTT Pharma deliver verified pen injector platform with sterile cartridge system
To support the industry shift from hospital to homecare including a more convenient drug administration for patients, Nemera, a world-leading provider of drug delivery device…
Lonza and Engitix Announce License Agreement to Advance Targeted ADC Development
Basel, Switzerland, and London, UK – Lonza, a contract development and manufacturing organization (CDMO), and Engitix, a global leader in ECM-based drug discovery and development,…
Samsung Biologics announces all-cash offer to acquire PolyPeptide
INCHEON, South Korea, -- Samsung Biologics has announced the launch of an all-cash public tender offer to acquire 100% of the fully diluted share capital…
Eli Lilly Makes $2.8 Billion Neuropsychiatry Acquisition
Another major move from Lilly - this time putting real capital behind psychedelics as a legitimate mental health treatment class. Why this matters: Treatment-resistant depression…
CellCarta Launches Digital Pathology and AI Consortium to Accelerate Platform-Agnostic Biomarker Innovation Across Drug Development
MONTREAL, CANADA, – CellCarta, a leading global CRO laboratory to the biopharmaceutical industry, today announced the launch of its Global Digital Pathology and AI Consortium,…
Sanofi’s subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector
Paris, The US Food and Drug Administration (FDA) has approved subcutaneous (SC) Sarclisa (isatuximab-irfc) Escena in combination with standard-of-care regimens for the treatment of patients with…
Atsena Therapeutics Selects ATSN-401 Clinical Candidate, a Potential Best-in-Class Gene Therapy for Stargardt Disease
DURHAM, NC, Atsena Therapeutics, a clinical-stage gene therapy company focused on reversing and preventing blindness from inherited retinal diseases, today announced the selection of a…
Gattefossé accelerates production ramp-up at its Lufkin facility with eight validated ingredients
Gattefossé, a leading provider of specialty ingredients and formulation solutions for the pharmaceutical and personal care industries, announces the successful validation of eight strategic ingredients…
Teva and Polpharma Biologics Announce Global Licensing Agreement for A Biosimilar Candidate to Ocrevus (ocrelizumab) for Multiple Sclerosis
TEL AVIV, ISRAEL, and Zug, Switzerland - Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd and Polpharma Biologics International AG today announced…
Evonik invests US$100 million to upgrade its U.S. drug substance contract manufacturing site
Essen, Germany. Evonik is making a significant investment to strengthen manufacturing capabilities at its Lafayette (Tippecanoe), Indiana facility. Over the next five years, the company…
Fonseca Biosciences Launches XTORO (finafloxacin otic suspension) 0.3% for Acute Otitis Externa
LONG BEACH TOWNSHIP, N.J. — Fonseca Biosciences, a specialty pharmaceutical company commercializing clinically differentiated pharmaceutical products, today announced the launch of XTORO (finafloxacin otic suspension),…
FUJIFILM Biotechnologies Selected in FDA PreCheck Pilot Program to Advance U.S. Drug Manufacturing
HOLLY SPRINGS, NC, FUJIFILM Biotechnologies (Fujifilm), a world-leading contract development and manufacturing organization (CDMO) for biologics, vaccines, and advanced therapies, today announced that its commercial-scale…
AustinPx Expands KinetiSol Technology Commercial Access through Thermo Fisher Scientific Collaboration
GEORGETOWN, Texas -- AustinPx, a contract development and manufacturing organization (CDMO) specializing in bioavailability enhancement for orally delivered small molecule drugs, today announced its agreement…
Codis To Acquire Catalent's Nottingham, UK Facility to Create Europe's Leading End-to-End Spray Dry Capability
HAVERHILL, England, Codis, a global contract development and manufacturing organization (CDMO) specializing in spray drying, amorphous solid dispersions (ASDs), and advanced particle engineering solutions, today…
BioPhorum Unites Regulators, Big Pharma and CDMOs to Accelerate Synthetic Molecule Innovation
LONDON - BioPhorum has announced the formation of the Synthetic Molecule Process Innovation Phorum, uniting an ecosystem of 20 leading organizations to urgently address the…
Lonza Expands HPAPI Capacity in Visp, Further Supporting its Position in Payload-Linker Manufacturing
Basel, Switzerland, – Lonza, a leading contract development and manufacturing organization (CDMO), today announced plans to enhance its drug-linker center of excellence and expand payload-linker…
Genmab and AbbVie Announce Topline Results for EPKINLY + lenalidomide in R/R DLBCL
Genmab and AbbVie announced positive topline results from the Phase 3 EPCORE DLBCL-4 trial. The trial met its primary objective, demonstrating statistically significant and clinically…
